A critique of the Montagnier evidence for the HIV/AIDS hypothesis

Medical Hypotheses

Volumn 63, Issue 4, 2004, Pages 597-601

  Papadopulos Eleopulos, Eleni ^a   Turner, Valendar F ^b   Papadimitriou, John ^c   Page, Barry ^a   Causer, David ^a   Alfonso, Helman ^d   Mhlongo, Sam ^e   Miller, Todd ^f   Maniotis, Andrew ^g   Fiala, Christian ^h  

^a ROYAL PERTH HOSPITAL   (Australia)

^b DEPARTMENT OF HEALTH   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g VA Chicago Hlth Care Syst W S   (United States)

^h Gynmed Ambulatorium   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNOREACTIVITY; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; REVIEW; SUCROSE DENSITY GRADIENT CENTRIFUGATION; SUPERNATANT; THEORETICAL STUDY; VIRUS PARTICLE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 8444234967     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.03.025     Document Type: Article

References (46)

1. Gallo R.C., Montagnier L. The discovery of HIV as the cause of AIDS. New Engl. J. Med. 349:2003;2283-2285
2. Shaw M.S., Wong-Staal F., Gallo R.C. Etiology of AIDS: virology, molecular biology, and evolution of human immunodeficiency viruses. DeVita V.T., Hellman S., Rosenberg S.A. AIDS etiology, diagnosis, treatment and prevention. second ed.:1988;J.B. Lippincott Company, Philadelphia
3. Levacher M., Hulstaert F., Tallet S., Ullery S., Pocidalo J.J., Bach B.A. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90:1992;376-382
4. Ludlam C.A., Steel C.M., Cheingsong-Popov R., et al. Human T-lymphotropic virus type-III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet. II:1985;233-236
5. Jason J.M., McDougal J.S., Dixon G., et al. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. J. Am. Med. Assoc. 255:1986;212-215
6. Detels R., English P.A., Giorgi J.V., et al. Patterns of CD4. + cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS J. Acquir. Immun. Defic. Syndr. 1:1988;390-395
7. Drew L.W., Mills J., Levy J., et al. Cytomegalic infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann. Int. Med. 103:1985;61-63
8. Novick D.M., Brown D.J.C., Lok A.S.F., Lloyd J.C., Thomas H.C. Influence of sexual preference and chronic Hepatitis B Virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activity. J. Hepatol. 3:1986;363-370
9. Papadopulos-Eleopulos E. A mitotic theory. J. Theor. Biol. 96:1982;741-758
10. Papadopulos-Eleopulos E. Reappraisal of AIDS: is the oxidation caused by the risk factors the primary cause? Med Hypotheses 1988;25:151-162. Available from: 〈http://www.theperthgroup.com〉
11. Papadopulos-Eleopulos E. Looking back on the oxidative stress theory of AIDS. Continuum. 5:1998;30-35 http://www.theperthgroup.com/CONTINUUM/ lookingback.html
12. Papadopulos-Eleopulos E., Turner V.F., Papadimitriou J.M. Oxidative stress, HIV and AIDS. Res. Immunol. 143:1992;145-148
13. Okamoto M., Byrn R., Eyre R.C., Mullen T., Church P., Kiessling A.A. Seminal plasma induces programmed cell death in cultured peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses. 18:2002;797-803
14. Dostal J., Veselsky L., Drahorad J., Jonakova V. Immunosuppressive effect induced by intraperitoneal and rectal administration of boar seminal immunosuppressive factor. Biol. Reprod. 52:1995;1209-1214
15. Prakash C., Coutinho A., Moller G. Inhibition of in vitro immune responses by a fraction from seminal plasma. Scand. J. Immunol. 5:1976;77-85
16. Des Jarlais D.C., Friedman S.R., Marmor M., et al. CD4 lymphocytopenia among injecting drug users in New York City. J. Acquir Immun. Defic Syndr. 6:1993;820-822
17. Nicolosi A., Musico M., Saracco A., Molinari S., Ziliani N., Lazzarin A. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and Northern Italy, 1987-1989. Epidemiology. 1:1990;453-459
18. Montagnier L. Lymphadenopathy-associated virus: from molecular biology to pathogenicity. Ann. Int. Med. 103:1985;689-693
19. Papadopulos-Eleopopulos E., Turner V.F., Papadimitriou J.M., Hedland-Thomas B., Causer D., Page B. A critical analysis of the HIV-T4-cell-AIDS hypothesis. Genetica. 95:1995;5-24
20. Beral V., Peterman T.A., Berkelman R.L., Jaffe H.W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection. Lancet. 335:1990;123-128
21. Papadopulos-Eleopulos E., Turner V.F., Papadimitriou J.M. Kaposi's sarcoma and HIV. Med Hypotheses. 39:1992;22-29
22. Gray R.H., Wawer M.J., Brookmeyer R., et al. Probability of HIV-1 transmission per coital act in monogamous heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet. 357:2001;1149-1153
23. Kamali A., Quigley M., Nakiyingi J., et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. 361:2003;645-652
24. Padian N.S., Shiboski S.C., Glass S.O., Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am. J. Epidemiol. 146:1997;350-357
25. Papadopulos-Eleopulos E., Turner V.F., Papadimitriou J.M., et al. Global voices on HIV/AIDS. Heterosexual transmission of HIV in Africa is no higher than anywhere else. Brit. Med. J. 324:2002;1035
26. Burton D., Desrosiers R., Doms R., et al. Public health: enhanced: a sound rationale needed for phase III HIV-1 vaccine trials. Science. 303:2004;316
27. Vilmer E., Rouzioux C., Vezinet Brun F., et al. Isolation of new lymphotropic retrovirus from two siblings with Haemophilia B, one with AIDS. Lancet. I:1984;753-757
28. Barré-Sinoussi F., Chermann J.C., Rey F., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 220:1983;868-871
29. Sinoussi F., Mendiola L., Chermann J.C. Purification and partial differentiation of the particles of murine sarcoma virus (M. MSV) according to their sedimentation rates in sucrose density gradients. Spectra. 4:1973;237-243
30. Gallo R.C., Sarin P.S., Wu A.M. On the nature of the nucleic acids and RNA dependent DNA polymerase from RNA tumor viruses and human cells. Silvestri L.G. Possible episomes in eukaryotes. 1973;13-34 North-Holland Publishing Company, Amsterdam
31. Weissbach A., Baltimore D., Bollum F. Nomenclature of eukaryotic DNA polymerases. Science. 190:1975;401-402
32. Ono K., Ohashi A., Yamamoto A., et al. Discrimination of reverse transcriptase from cellular DNA polymerase by kinetic analysis. Cell. Mol. Biol. 25:1980;323-328
33. Rey M.A., Spire B., Dormont D., Barre-Sinoussi F., Montagnier L., Chermann J.C. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem. Biophys. Res. Commun. 121:1984;126-133
34. Pachacz M. No need to be phased. Shares. 2001;28-32
35. Montagnier L. Historical accuracy of HIV isolation. Nat. Med. 9:2003;1235
36. Klatzmann D., Barré-Sinoussi F., Nugeyre M.T. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 225:1984;59-63
37. Beard J.W. Physical methods for the analysis of cells. Ann. NY Acad. Sci. 69:1957;530-544
38. Grafe A. A history of experimental virology. 1991;Springer, Heidelberg
39. Panem S., Prochownik E.V., Reale F.R. Isolation of type C virions from a normal human fibroblast strain. Science. 189:1975;297-299
40. Gallo R.C., Wong-Staal F., Reitz M., Gallagher R.E., Miller N., Gillespie D.H. Some evidence for infectious type-C virus in humans. Balimore D., Huang A.S., Fox C.F. Animal virology. 1976;385-405 Academic Press, New York
41. Todaro G.J., Benveniste R.E., Sherr C.J. Interspecies transfer of RNA tumour virus genes: implications for the search for human type C viruses. Baltimore D., Huang A.S., Fox C.S. Animal virology. 1976;369-384 Academic Press, New York
42. The presence of budding virus-like particles in human lymphoid cells used for HIV cultivation. VIIth International Conference on AIDS; 1991; Florence
43. O'Hara C.J., Groopman J.E., Federman M. The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related and non-human immunodeficiency virus-related lymphadenopathy syndromes. Hum. Pathol. 19:1988;545-549
44. Tahi D. Did Luc Montagnier discover HIV? Text of video interview with Professor Luc Montagnier at the Pasteur Institute July 18th 1997. Continuum 1998;5:30-34. Available from: 〈http://www.theperthgroup.com/CONTINUUM/ djamelmontagnier.html〉
45. Ternynck T., Avrameas S. Murine natural monoclonal antibodies: a study of their polyspecificities and their affinities. Immunol. Rev. 94:1986;99-112
46. Barre-Sinoussi F. Historical accuracy of HIV isolation-reply. Nat. Med. 9:2003;1235-1236